Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 02-Apr 2007. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 35784501000001117 | 3,4-Diaminopyridine 20mg tablets (Small Scale Pharmaceuticals (Brighton) Ltd) 100 tablet (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 37666201000001117 | 3,4-Diaminopyridine 20mg tablets (Special Order) 100 tablet | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| 3,4-Diaminopyridine 20mg tablets (Small Scale Pharmaceuticals (Brighton) Ltd) 100 tablet | Is a | 3,4-Diaminopyridine 20mg tablets 100 tablet | false | Inferred relationship | Existential restriction modifier | ||
| 3,4-Diaminopyridine 20mg tablets (Small Scale Pharmaceuticals (Brighton) Ltd) 100 tablet | Is pack of | 3,4-Diaminopyridine 20mg tablets (Small Scale Pharmaceuticals (Brighton) Ltd) | false | Inferred relationship | Existential restriction modifier | ||
| 3,4-Diaminopyridine 20mg tablets (Small Scale Pharmaceuticals (Brighton) Ltd) 100 tablet | Has active ingredient | 3,4-Diaminopyridine | false | Inferred relationship | Existential restriction modifier | ||
| 3,4-Diaminopyridine 20mg tablets (Small Scale Pharmaceuticals (Brighton) Ltd) 100 tablet | Has manufactured dose form | Tablet | false | Inferred relationship | Existential restriction modifier | ||
| 3,4-Diaminopyridine 20mg tablets (Small Scale Pharmaceuticals (Brighton) Ltd) 100 tablet | Has excipient | Excipient not declared | false | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR